A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat

This publication has 26 references indexed in Scilit:

• Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations
  Contraception, 1999
• Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons
  American Journal of Obstetrics and Gynecology, 1998
• Oral contraceptive practice guidelines
  Contraception, 1998
• Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, on lipid metabolism in an open randomized trial
  Contraception, 1996
• Attitudes to current oral contraceptive use and future developments: The women's perspective
  The European Journal of Contraception & Reproductive Health Care, 1996
• A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and tolerance
  Contraception, 1995
• Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiol
  Contraception, 1995
• Clinical aspects of three new progestogens: Desogestrel, gestodene, and norgestimate
  American Journal of Obstetrics and Gynecology, 1989
• A new low-dose estrogen oral contraceptive combination: Effect on endocrine parameters and lipid status
  Contraception, 1987
• Effect of low-dose progestogen-estrogen combination (WL-20) on the menstrual cycle of sexually active women of childbearing age
  Contraception, 1974